These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 913955)

  • 21. Criteria for evaluating hormones in the 7,12-dimethylbenz[a]-anthracene-induced mammary tumor-rat experimental chemotherapy system.
    Teller MN; Kaufman RJ; Stock CC; Bowie M
    Cancer Res; 1968 Feb; 28(2):368-71. PubMed ID: 5694312
    [No Abstract]   [Full Text] [Related]  

  • 22. Antitumor and endocrine effects of an aromatase inhibitor (CGS 16949A) on DMBA-induced rat mammary tumor.
    Houjou T; Wada T; Yasutomi M
    Clin Ther; 1993; 15(1):137-47. PubMed ID: 8458043
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Androgen therapy.
    Longson D
    Practitioner; 1972 Mar; 208(245):338-48. PubMed ID: 4557109
    [No Abstract]   [Full Text] [Related]  

  • 24. Human chorionic gonadotropin inhibits N-Methyl-N-nitrosourea-induced mammary carcinoma growth in female Lewis rats.
    Yuri T; Lai YC; Yoshizawa K; Tsubura A
    In Vivo; 2012; 26(3):361-7. PubMed ID: 22523287
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antitumor actions of keoxifene and tamoxifen in the N-nitrosomethylurea-induced rat mammary carcinoma model.
    Gottardis MM; Jordan VC
    Cancer Res; 1987 Aug; 47(15):4020-4. PubMed ID: 3607747
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Adjuvant endocrine therapy for operable breast cancer using the antiestrogen mepitiostane: a preliminary report.
    Nomura Y; Yamagata J; Takenaka K; Kanda K
    Gan; 1980 Aug; 71(4):548-56. PubMed ID: 6893588
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of 2alpha, 3alpha-epithio-5alpha-androstan-17beta-ol (epitiostanol) on hypothalamo-pituitary-gonadal axis in humans.
    Kurachi K; Aono T; Tomoyama J; Matsumoto K; Nakasima A
    Acta Obstet Gynaecol Jpn; 1975 Jan; 22(1):42-8. PubMed ID: 1224948
    [No Abstract]   [Full Text] [Related]  

  • 28. Chlropyrifos-methyl shows anti-androgenic activity without estrogenic activity in rats.
    Kang HG; Jeong SH; Cho JH; Kim DG; Park JM; Cho MH
    Toxicology; 2004 Jul; 199(2-3):219-30. PubMed ID: 15147795
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Apparent bioisosteric replacement of--S--by NCN: synthesis of N--cyano-2-aza-A-nor-5alpha-androstan-17beta-ol acetate, an aza steroid androgen.
    Chiu WH; Klein TH; Wolff ME
    J Med Chem; 1979 Jan; 22(1):119-20. PubMed ID: 423176
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effect of second-line antiestrogen therapy on breast tumor growth after first-line treatment with the aromatase inhibitor letrozole: long-term studies using the intratumoral aromatase postmenopausal breast cancer model.
    Long BJ; Jelovac D; Thiantanawat A; Brodie AM
    Clin Cancer Res; 2002 Jul; 8(7):2378-88. PubMed ID: 12114443
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prolactin and growth hormone levels in the anterior pituitary of rats bearing mammary tumor induced by 7,12-dimethylbenz [a] anthracene.
    Yanai R; Nagasawa H
    Gan; 1968 Dec; 59(6):543-6. PubMed ID: 5721587
    [No Abstract]   [Full Text] [Related]  

  • 32. [Introduction of a new aromatase inhibitor fadrozole hydrochloride hydsate].
    Tsukagoshi S
    Gan To Kagaku Ryoho; 1995 Nov; 22(13):1991-7. PubMed ID: 7487133
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Benzo[d,e]testosterone acetate: a new synthetic steroid with dissociation of biological activities.
    Briziarelli G
    Endocrinology; 1967 Aug; 81(2):390-4. PubMed ID: 5006459
    [No Abstract]   [Full Text] [Related]  

  • 34. The effect of the sex hormones on the growth of transplanted mammary adenofibroma in rats.
    Mohs FE
    Am J Cancer; 1940 Feb; 38(2):212-6. PubMed ID: 12279175
    [TBL] [Abstract][Full Text] [Related]  

  • 35. NTP Toxicology and Carcinogenesis Studies of Oxymetholone (CAS NO. 434-07-1) in F344/N Rats and Toxicology Studies of Oxymetholone in B6C3F1 Mice (Gavage Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1999 Aug; 485():1-233. PubMed ID: 12571678
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Steroid hormone receptors as targets for the therapy of breast and prostate cancer--recent advances, mechanisms of resistance, and new approaches.
    Hoffmann J; Sommer A
    J Steroid Biochem Mol Biol; 2005 Feb; 93(2-5):191-200. PubMed ID: 15860262
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Clinical experience with Furazabol in mammary tumors, with special emphasis on mastopathy].
    Watanuki S; Ito K; Nishikawa Y; Ajisaka H
    Geka Chiryo; 1969 Apr; 20(4):470-4. PubMed ID: 5819735
    [No Abstract]   [Full Text] [Related]  

  • 38. Prevention of digitoxin poisoning by various steroids.
    Selye H; Jelinek J; Krajny M
    J Pharm Sci; 1969 Sep; 58(9):1055-9. PubMed ID: 5346064
    [No Abstract]   [Full Text] [Related]  

  • 39. Effects of tamoxifen on mammary tumors and bone in 7,12-dimethylbenz-(a)anthracene-treated rats.
    Suzuki S; Kitamura S; Sakamoto S; Sassa S; Mitamura T; Kudo H; Kuwa K; Yoshimura S; Maemura M; Nakayama T; Zhou YF; Hara Y; Shinoda H; Nagasawa H
    Anticancer Res; 1998; 18(2A):871-6. PubMed ID: 9615734
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Anabolic and androgenic activity of 19-norandrostenedione after oral and subcutaneous administration--analysis of side effects and metabolism.
    Parr MK; Laudenbach-Leschowsky U; Höfer N; Schänzer W; Diel P
    Toxicol Lett; 2009 Jul; 188(2):137-41. PubMed ID: 19446246
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.